Flash FinanceUS
After hours S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · GeoVax Labs, Inc. (GOVX)

GeoVax terminates CEO David Dodd for Cause; he stays as chairman and may dispute

Negative Impact 4 of 5 leadership

GeoVax Labs said on November 5, 2026 that its Board terminated David A. Dodd as President and Chief Executive Officer, effective immediately, and treated the termination as for Cause under his 2018 Employment Agreement. Dodd remains a director and Chairman, and the company does not intend to pay the severance he would receive without Cause, but he may dispute the determination, which could lead to severance and option-vesting costs.

Key points

  • Termination of President and CEO David A. Dodd effective immediately, dated November 5, 2026; he remains a director and Chairman
  • Board cites Dodd's refusal to comply with Board-approved directives as the basis for Cause
  • Company does not intend to pay severance, including a cash payment of three times base salary and target bonus, or full option vesting; Dodd may dispute and claim these
  • Company states the termination is unrelated to its business operations, financial results, or previously filed financial statements

The filing

CompanyGeoVax Labs, Inc. (GOVX)
Form8-K, current report
Filed with the SECNov 6, 2026, 4:22 PM ET
Accession number0001437749-26-035579

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 7:05 AM ET, from this filing only.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.